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ABSTRACT
The methylcytosine dioxygenases TET proteins (TET1,
TET2, and TET3) play important regulatory roles in
neural function. In this study, we investigated the role of
TET proteins in neuronal differentiation using Neuro2a
cells as a model. We observed that knockdown of TET1,
TET2 or TET3 promoted neuronal differentiation of
Neuro2a cells, and their overexpression inhibited VPA
(valproic acid)-induced neuronal differentiation, sug-
gesting all three TET proteins negatively regulate neu-
ronal differentiation of Neuro2a cells. Interestingly, the
inducing activity of TET protein is independent of its
enzymatic activity. Our previous studies have demon-
strated that srGAP3 can negatively regulate neuronal
differentiation of Neuro2a cells. Furthermore, we
revealed that TET1 could positively regulate srGAP3
expression independent of its catalytic activity, and
srGAP3 is required for TET-mediated neuronal differen-
tiation of Neuro2a cells. The results presented here may
facilitate better understanding of the role of TET proteins
in neuronal differentiation, and provide a possible ther-
apy target for neuroblastoma.
KEYWORDS methylcytosine dioxygenase, TET1,
srGAP3, neuronal differentiation, neuroblastoma cells
INTRODUCTION
DNA methylation at the 5-position of cytosine (5-methylcy-
tosine, 5mC) is an important epigenetic mark involved in
regulation of gene expression. Ten-eleven translocation
proteins (TET1, TET2, and TET3) are a family of Fe (II) and
α-ketoglutarate-dependent dioxygenases that are capable of
oxidizing 5mC to 5-hydroxymethylcytosine (5hmC) and fur-
ther to generate 5-formylcytosine (5fC) and 5-carboxylcy-
tosine (5caC) (Pastor et al., 2013; Ito et al., 2011). TET family
proteins share highly homologous protein structural features.
All TET proteins contain a C-terminal double stranded β-
helix catalytic domain, and both TET1 and TET3 have an
N-terminal CXXC domain, while TET2 CXXC domain IDAX
(also known as CXXC4) is separated from TET2 following
chromosomal rearrangement during evolution (Fig. 1A).
The TET family members were identiﬁed to possess a
catalytic enzymatic activity conversion 5mC to 5hmC in 2009
(Tahiliani et al., 2009). TET proteins had been proved to be
critical for numerous biological processes such as embryonic
development, stem cell differentiation, immune regulation,
and cancer formation (Tan and Shi, 2012; Xu et al., 2012; Li
et al., 2015; Zhang et al., 2015; Dawlaty et al., 2013; Cim-
mino et al., 2015; Neri et al., 2015; Scourzic et al., 2015).
Importantly, 5hmC was ﬁrst to identify highly enriched in
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Purkinje cells and the brain tissues, suggesting a potential
biological function of 5hmC in these cells and tissues (Kri-
aucionis and Heintz, 2009). Indeed, accumulating evidence
demonstrates that TET proteins play important roles in the
regulation of neural function (Yao and Jin, 2014). For
example, TET1 deﬁciency in mice results in impaired neu-
rogenesis and memory (Zhang et al., 2013; Kaas et al.,
2013); knockdown of TET2 and TET3 in the mouse cerebral
cortex leads to a block in neuronal differentiation (Hahn
et al., 2013); TET3 is essential for early eye development in
Xenopus (Xu et al., 2012). The roles of TET proteins in
transcriptional regulation have been extensively investigated
(Pastor et al., 2013). In most cases, TET-mediated promoter
hypomethylation facilitates gene expression (Ficz et al.,
2011; Mariani et al., 2014; Wu et al., 2011) in a dioxygenase
activity-dependent manner.
Besides the catalytic domains, the CXXC domains are
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The CXXC domains are important for TET proteins binding
to speciﬁc genomic regions for their action (Xu et al., 2012;
Tan and Shi, 2012; Jin et al., 2014), and they can cooperate
with the catalytic domain to regulate the key gene expression
(Xu et al., 2012; Ko et al., 2013). Interestingly, accumulating
evidence suggests that the non-catalytic TET proteins also
play important roles in regulating gene expression (Pastor
et al., 2013), whereas the regulation mechanisms are far
from being fully elucidated.
Neuro2a is a mouse neural crest-derived cell line that has
been widely used as an experimental model for neuronal
differentiation study. In our previous studies, we used this
model to study the role of srGAP3 in neuronal differentiation,
and we found srGAP3 negatively regulated valproic acid
(VPA)-induced neuronal differentiation of Neuro2a cells
(Chen et al., 2011; Ma et al., 2013). In this study, we
investigated the role of TET proteins during neuronal differ-
entiation using Neuro2a cells as a model. We found that all
three TET proteins could negatively regulate neuronal dif-
ferentiation of Neuro2a cells. Furthermore, TET1 can nega-
tively modulate neuronal differentiation independent of its
catalytic activity and through srGAP3.
RESULTS
The expression of TET proteins is not correlated
with 5hmC level in Neuro2a cells
To investigate the roles of TET proteins in neuronal differ-
entiation, we ﬁrstly detected TET1–3 expression in Neuro2a
cells. Three polyclonal antibodies speciﬁc against TET1,
TET2, and TET3 protein were applied in the study
(Fig. 1A). Immunoﬂuorescence staining was performed to
visualize the subcellular localization of endogenous TET
proteins (Fig. 1B and 1C). It could be clearly observed that
all three TET proteins expressed at detectable levels and
localized to the nuclei either in uninduced (UI) or VPA-in-
duced (VPA) Neuro2a cells (Fig. 1B and 1C). TuJ1 was
used as a neuronal differentiation marker to indicate the
differentiation stages (Fig. 1D). qRT-PCR indicated that the
expression levels of TET1 and TET2 but not TET3 were
remarkably increased after VPA stimulation for 24 h
(Fig. 1E–G).
However, it was reported that 5hmC level is low in Neu-
ro2a cells (Kriaucionis and Heintz, 2009), and this conclu-
sion was conﬁrmed in this study. 5hmC level could be
detected by spotting as much as 800 ng DNA in Neuro2a
cells (Fig. 1H), compared to only 25 ng DNA in mouse
cerebral cortex tissues (Fig. 1I). In addition, 5hmC level
increased gradually during VPA-induced Neuro2a cells dif-
ferentiation (Fig. 1H). Those results indicated Neuro2a cells
maintained high level of TET proteins and lower level of
5hmC. The mismatch between TET proteins and 5hmC
suggested the catalytic activities of TET proteins might be
suppressed in Neuro2a cells.
Knockdown of endogenous TET proteins promote
neuronal differentiation of Neuro2a cells
TET proteins play important roles in neuronal development;
however, the regulatory mechanisms of TET family proteins
remain largely unknown. Here we examined the effects of
TET1, TET2, or TET3 depletion on Neuro2a cells by shRNA-
based knockdown method. The plasmid pGPU6/GFP/Neo
under the control of hU6 promoter and cytomegalovirus
immediate-early promoter (Pcmv IE) was used to express
shRNA and GFP, respectively (Fig. 2A). The Neuro2a cells
transfected with either negative control or shRNA expressing
vectors could be recognized by expression of GFP. Cells
with neurite processes longer than 1.5 cell bodies were
counted as differentiated cells (Fig. 2B). qRT-PCR analysis
demonstrated the efﬁciency of knockdown (Fig. 2C–E). We
then examined the effects of TET proteins knockdown on
Neuro2a cells differentiation. As shown in Fig. 2F–G, TET
proteins depletion promoted neuronal differentiation in
Neuro2a cells. The differentiation rate of the two TET1
knockdown groups (TET1 KD1 and TET1 KD2) were 6.7%
and 9.6%, respectively, in uninduced Neuro2a cells (UI)
compared to the control group (NC) which was 2.9%
Figure 1. Lower 5hmC level and higher expression of TET
proteins in Neuro2a cells. (A) Schematic presentation of the
structure of TET proteins. The antigenic epitopes of the three
TET antibodies on the corresponding TET proteins are under-
lined. (B) The expression and localization of endogenous TET
proteins in Neuro2a cells cultured in high glucose DMEM
containing 10% FBS (Uninduced, UI). The lower panels show
magniﬁcations of the single cell and process outlined by the
white box in the upper panels respectively. Scale bar = 100 μm.
(C) The expression and localization of endogenous TET
proteins in opti-MEM containing 1 mmol/L VPA (VPA-induced,
VPA) for 24 h. GAP43 was used as a neuronal differentiation
marker. The lower panels show magniﬁcations of the single cell
and process outlined by the white box in the upper panels
respectively. Scale bar = 100 μm. (D) Western blotting was
used to detect the expression level of TuJ1 in uninduced
Neuro2a cells (UI), and Neuro2a cells after VPA stimulation
(VPA) for 2 h or 24 h. The relative expression level of TuJ1 was
calculated by TuJ1/α-Tubulin. (E–G) Quantiﬁcation of relative
mRNA levels of endogenous TET proteins in uninduced
Neuro2a cells (UI) and Neuro2a cells after VPA stimulation
(VPA) for 2 h or 24 h. GAPDH was used as internal control.
(H) Dot blotting was performed to analyze the 5hmC level in
uninduced Neuro2a cells (UI), and Neuro2a cells after VPA
stimulation (VPA) for 2 h or 24 h. DNA samples were serially
two-fold diluted from 800 ng to 100 ng. 5hmC level was
detected by using anti-5hmC antibody and the total DNA was
stained by methylene blue. The relative level of 5hmC was
calculated by 5hmC/DNA. (I) Dot blotting was used to analyze
the 5hmC level in P15 mouse cerebral cortex tissues.
b
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(Fig. 2F), and were 29.2% and 27.8% in VPA-induced
Neuro2a cells (VPA), respectively, compared to the control
group, which was 20.9% (Fig. 2G). Additionally, similar
effects on neuronal differentiation in Neuro2a cells could be
observed after knockdown of TET2 (TET2 KD1 and TET2
KD2) or TET3 (TET3 KD1 and TET3 KD2) (Fig. 2F–G).
Furthermore, we tested whether knockdown of TET pro-




































































































































































































































































































































Figure 2. Knockdown of TET proteins facilitate the neuronal differentiation of Neuro2a cells. (A) Schematic presentation of
shRNA expression vector. hU6 promoter, human U6 promoter; Pcmv IE, cytomegalovirus immediate-early promoter; GFP, green
ﬂuorescent protein. Neuro2a cells transfected with shRNA expression vectors were visualized by GFP. (B) Representative images of
uninduced Neuro2a cells (UI) and Neuro2a cells after VPA stimulation (VPA) for 24 h. Arrowheads indicate the differentiated cells.
Cells with processes longer than 1.5 cell bodies are considered as differentiated cells. Scale bar = 100 μm. (C–E) shRNA expression
vectors of TET1–3 were transfected into Neuro2a cells, and qRT-PCR was used to analyze the effects of TET proteins knockdown.
GAPDH was used as internal control. (F and G) Quantiﬁcations of the differentiation rates from Neuro2a cells of negative control (NC)
and TET1, TET2, or TET3 knockdown in the absence (UI) or presence of VPA stimulation (VPA) for 24 h. Two shRNAs targeted
different positions were designed respectively for each gene. (H–J) Assessment of neurite outgrowth of VPA-induced Neuro2a cells
after TET1, TET2, or TET3 knockdown. Three endpoints were quantiﬁed: total neurite length (H), longest neurite length (I), and
neurite number per cell (J). Values are mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001.
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Neuro2a cells. The results showed that knockdown of TET1,
TET2, or TET3 did not affect total neurite length (Fig. 2H),
longest neurite length (Fig. 2I), and neurite number (Fig. 2G),
suggesting that TET proteins could not alter neurite out-
growth in differentiated Neuro2a cells.
Overexpression of TET proteins inhibit neuronal
differentiation of VPA-induced Neuro2a cells
We next tested whether overexpression of TET proteins
could affect neuronal differentiation of Neuro2a cells. The
plasmid harboring TET1, TET2, or TET3 gene was trans-
fected into Neuro2a cells (Fig. 3A). TET1 overexpression in
Neuro2a cells had an approximately 47.0% inhibitory effect
on neuronal differentiation by VPA stimulation (Fig. 3B). The
differentiation rate was reduced to 10.5% compared to
control, which was 19.8% (Fig. 3B). Similarly, overexpres-
sion of TET2 or TET3 also leads to a remarkable reduction in
differentiation rates (TET2 overexpression: 17.1%; TET3
overexpression: 13.7%) (Fig. 3B). The results demonstrated
that TET family proteins are negative regulators in neuronal
differentiation of Neuro2a cells.
TET proteins enrich 5hmC in Neuro2a cells
It is well known that TET proteins are able to convert 5mC to
5hmC, and enrich 5hmC in the cells. Given a mismatch
between TET proteins and 5hmC levels (Fig. 1), we asked
whether the overexpressed TET proteins kept their catalytic
activities in the Neuro2a cells. As shown in Figure. 4, over-
expression of TET1, TET2, or TET3 in Neuro2a cells can
slightly increase 5hmC level. Importantly, the 5hmC levels
were further increased after VPA stimulation for 24 h. The
results suggested their catalytic activities were retained after
TET protein overexpression, and the activities might be
enhanced by VPA stimulation. However, whether this activity
was involved in the regulation of neuronal differentiation of
Neuro2a cells was unknown.
Overexpression of non-catalytic TET1 inhibits Neuro2a
cells differentiation
As TET1, TET2, and TET3 showed similar effect on Neuro2a
differentiation, and all of them shared similar homologous
regions, we chose TET1 as a representative for further
study. While both dioxygenase and CpG binding activity are
critical for TET1 function, it has been reported that TET1
could exert its effect through enzymatic activity-independent
manner (Kaas et al., 2013; Wu et al., 2011; Williams et al.,
2011). To explore whether the regulation of Neuro2a cells
differentiation by TET1 is dependent on its enzymatic activ-
ity, we also tested the effects of inactive mutants of TET1
with CpG binding domain CXXC deletion mutant (dCXXC)
and catalytic domain mutant (CD mut), respectively (Fig. 5A).
The plasmids harboring wild type (WT) TET1, TET1 dCXXC
(dCXXC), or TET1 CD mut (CD mut) genes, were trans-
fected into Neuro2a cells. Western blotting conﬁrmed the
expression of those proteins (Fig. 5B), and immunocyto-
chemistry conﬁrmed that CD mut lost its catalytic activity,
while the dCXXC retained it (Fig. 5C).
Next, we investigated the effects on neuronal differentia-
tion in VPA-induced Neuro2a cells following transfection of
these three plasmids. Interestingly, transfection of all three
constructs including WT TET1 (TET1), dCXXC, and CD mut
signiﬁcantly inhibited Neuro2a cells differentiation (Fig. 5D






















































Figure 3. Overexpression of TET proteins inhibits VPA-
induced neuronal differentiation of Neuro2a cells.
(A) Neuro2a cells transfected with control vector (Vector)
or vector harboring TET1, TET2, or TET3 gene were co-
immunostained with Flag and GAP43 antibodies. Arrow-
heads indicate the differentiated cells and arrows indicate
the undifferentiated cells. Scale bar = 100 μm. (B) Quan-
tiﬁcations of the differentiation rates from Neuro2a cells in
the absence (UI) or presence of VPA stimulation (VPA) for
24 h. Values are mean ± SEM, *P < 0.05, ***P < 0.001.
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differentiation of Neuro2a cells in an enzymatic activity-in-
dependent manner.
TET1 positively regulates srGAP3 expression
independent of its catalytic domain
Since TET1 has been demonstrated to regulate a series of
gene expression, we asked whether TET1 could modulate
srGAP3 expression. We examined srGAP3 expression after
TET1 knockdown and overexpression by Western blotting.
TET1 KD1, one of the two shRNA expressing vectors, which
was more effective than the other, was selected for subse-
quent research. Indeed, the results showed that knockdown
of endogenous TET1 by transfection of shRNA against TET1
decreased protein levels of srGAP3 either in uninduced (UI)
or VPA-induced (VPA) Neuro2a cells (Fig. 6A), while
overexpression of TET1 increased srGAP3 expression
(Fig. 6B). In our previous studies, srGAP3 was illustrated to
negatively regulate neuronal differentiation of VPA-induced
Neuro2a cells in a Rac1-dependent manner (Chen et al.,
2011; Ma et al., 2013). Thus, we speculated that TET1 might
negatively regulate neuronal differentiation of Neuro2a cells
via modulating the expression of srGAP3. Considering that
wild type (WT) TET1 can positively regulate the srGAP3
expression, we wonder whether the TET1 mutants can also
modulate the srGAP3 expression. We examined the srGAP3
expression level following overexpression of WT TET1
(TET1), dCXXC, and CD mut in Neuro2a cells. As shown in
Figure 6C, overexpression of WT TET1 (TET1), dCXXC, and
CD mut can upregulate srGAP3 expression.
To conﬁrm if srGAP3 can reverse the neuronal differen-
tiation inducing activity of TET1-depleted neuro2a cells, we
then quantiﬁed the differentiation rate of Neuro2a cells co-
transfected with the knockdown construct for TET1 and
srGAP3 overexpression vectors. As expected, overexpres-
sion of srGAP3 efﬁciently attenuated VPA-induced neuronal
differentiation of TET1-depleted Neuro2a cells (Fig. 6D and
6E), indicating that TET1 negative regulate neuronal differ-
entiation through srGAP3 expression, independent of its
enzymatic activity (Fig. 6F).
DISCUSSION
Accumulating evidence indicates that TET proteins regulate
neuronal activity-related gene expression, neuronal survival,
neural development, and memory formation (Zhang et al.,
2013; Kaas et al., 2013; Rudenko et al., 2013). In this study,
we employed a Neuro2a cell model to explore the effect of
TET family proteins on neural differentiation in vitro. We
demonstrated TET proteins could negatively regulate neu-
ronal differentiation of Neuro2a cells, and this regulation is
independent of enzymatic activity of TET1. Furthermore,
non-catalytic TET1 could negatively regulate neuronal dif-
ferentiation through upregulating srGAP3.
Both the catalytic domain and CXXC domain are impor-
tant for TET protein enzymatic activity. Mutations of the TET
catalytic domain and CXXC domain can reduce their enzy-
matic-activity-dependent function (Hsu et al., 2012). Besides
functioning in an enzymatic dependent manner, TET pro-
teins can also regulate gene transcription independent of
their catalytic activities. For examples, TET1 is found to
repress gene transcription through binding to Polycomb
group target genes, which is independent of its catalytic
activity (Williams et al., 2011; Wu et al., 2011), and it can also
upregulate several neuronal memory-associated genes
independent of its enzymatic activity (Kaas et al., 2013).
Similarly, TET2 was identiﬁed to recruit histone deacetylases
2 (Hdac2) to repress IL-6 transcription independent of DNA
methylation and hydroxymethylation (Zhang et al., 2015).
Additionally, catalytically inactive TET3 mutant can partially
rescue the effect on Xenopus eye and neural development
TET2 (c-myc) 5hmC DAPI Merge
TET3 (c-myc) 5hmC DAPI Merge










Figure 4. Overexpression of TET proteins increased 5hmC
levels in differentiated Neuro2a cells. (A–C) Neuro2a cells
were cultured in high glucose DMEM containing 10% FBS (UI)
or in opti-MEM containing 1 mmol/L VPA (VPA). 5hmC and the
expression of GFP tagged TET1 (A), c-myc tagged TET2 (B), or
c-myc tagged TET3 (C) was detected by co-immunoﬂuores-
cence staining.
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after TET3 depletion, suggesting an enzymatic activity-in-
dependent mechanism in gene regulation (Xu et al., 2012).
These ﬁndings point out a critical role of TET-mediated gene
regulation independent of enzymatic activity. In this study, we
uncovered that the differentiation rate was signiﬁcantly
decreased after overexpression of both the TET1 dCXXC
and TET1 CD mutant, showing that the neuronal differenti-
ation of Neuro2a cells was negatively regulated by TET1 in a
dioxygenase activity-independent manner. Furthermore,
overexpression of TET1 mutants resulted in a stronger
C D
E














































































Figure 5. Overexpression of TET1 mutants inhibits neuronal differentiation of Neuro2a cells. (A) Schematic presentation of
structure of TET1 mutants. (B) Neuro2a cells transfected with control vector (Vector) or vector harboring WT TET1 (TET1), TET1
dCXXC (dCXXC), and TET1 CD mut (CD mut) were lysed and immunoblotted with TET1 antibody. (C) Immunostaining of 5hmC after
overexpression of WT TET1 (TET1), TET1 dCXXC (dCXXC), and TET1 CD mut (CD mut). (D) Neuro2a cells transfected with control
vector (Vector) or vector harboring WT TET1 (TET1), TET1 dCXXC (dCXXC), and TET1 CD mut (CD mut) gene were co-
immunostained with Flag and GAP43 antibodies. Arrowheads indicate the differentiated cells and arrows indicate undifferentiated
cells. Scale bar = 100 μm. (E) Quantiﬁcation of the differentiation rates from Neuro2a cells after overexpression of WT TET1 (TET1),
TET1 dCXXC (dCXXC), and TET1 CD mut (CD mut). Values are mean ± SEM, ***P < 0.001.
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inhibitory effect on neuronal differentiation even than that of
overexpression of WT TET1 (TET1) (Fig. 5E). That might be
because WT TET1 may exert an opposite effect on neuronal
differentiation in an enzymatic activity-dependent manner.
TET1 can regulate the srGAP3 expression, and this
regulation is independent of the catalytic activity of TET1. As
srGAP3 can negatively regulate neuronal differentiation of
Neuro2a cells, we speculate TET1 may negatively regulate
Neuro2a cells differentiation via modulating the expression
of srGAP3. Since many proteins have been found to interact
with TET proteins to regulate gene expression (Yao and Jin
2014; Qiao et al., 2015; Wang et al., 2015; Perera et al.,
2015), the regulation of srGAP3 expression may be due to
the interaction between TET1 with some unknown proteins.
However, the precise mechanism of neuronal differentiation
regulated by TET1 should be further investigated.
In addition, the mRNA levels of TET1 and TET2 were
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Figure 6. TET1 inhibits neuronal differentiation of Neuro2a cells independent of catalytic activity through srGAP3.
(A) Western blotting was used to measure the srGAP3 level after endogenous TET1 knockdown in uninduced Neuro2a cells (UI), and
Neuro2a cells after VPA stimulation (VPA) for 24 h. (B) Western blotting was used to measure the srGAP3 level after TET1
overexpression in uninduced Neuro2a cells (UI), and Neuro2a cells after VPA stimulation (VPA) for 24 h. (C) Western blotting was
used to analyze srGAP3 level after overexpression of WT TET1 (TET1), TET1 dCXXC (dCXXC), and TET1 CD mut (CD mut). The
relative expression level of srGAP3 was calculated by srGAP3/α-Tubulin. (D) SrGAP3 overexpression constructs or control vector
and RFP were co-transfected into the normal or TET1-depleted Neuro2a cells, which were induced by VPA for 24 h. Arrowheads
indicate the differentiated cells and arrows indicate undifferentiated cells. Scale bar = 100 μm. (E) Cell differentiation rate in (C) was
analyzed. (F) A proposed working model for TET1 functions in regulating neuronal differentiation. Catalytic activity of TET1 might be
suppressed in Neuro2a cells, and non-catalytic activity of TET1 inhibited neuronal differentiation through srGAP3 and Rac1 pathway.
Values are mean ± SEM, **P < 0.01.
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has been reported that VPA inhibit histone deacetylases
(HDACs) to relieve HDAC-mediated transcriptional repres-
sion (Göttlicher et al., 2001). Thus, the increased mRNA of
TET1 and TET2 may be due to the increase of histone
acetylation level by VPA treatment. Furthermore, 5hmC
levels were also increased in VPA-induced Neuro2a cells.
These results were consistent with previous observations
that levels of 5hmC increased during neuronal differentiation
(Hahn et al., 2013). It also suggested the inhibition of cat-
alytic activity of TET proteins might be relieved during neu-
ronal differentiation of Neuro2a cells.
Neuroblastoma is the most common extracranial solid
tumor of early childhood. Induction of terminal differentiation
is a therapeutic approach for neuroblastoma treatment
(Brodeur and Bagatell, 2014). In this study, we found TET
proteins could negatively regulate neuronal differentiation of
mouse neuroblastoma Neuro2a cells. It suggested inhibition
of TET protein expression might be a promising approach for
neuroblastoma therapy. Furthermore, in a previous report, it
was suggested that hypoxia leads to transcriptional activa-
tion of TET1, which facilitated hypoxic gene induction in
neuroblastoma (Mariani et al., 2014), showing the important
role of TET1 in neuroblastoma development. The results
further indicated TET1 might serve as a promising thera-
peutic target in neuroblastoma.
In summary, we found TET1 could negatively regulate
neuronal differentiation of Neuro2a cells independent of its
enzymatic activity through srGAP3. This study might provide
a better understanding for the role of TET proteins in neu-




Three homemade TET1 (from 146 to 159 amino acid residues), TET3
(from 1598 to 1610 amino acid residues), and srGAP3 (from 1088 to
1099 amino acid residues) antigen afﬁnity antibodies were used in our
previous studies (Zhao et al., 2014; Mi et al., 2015; Fu et al., 2014).
These antibodies were puriﬁed by antigen afﬁnity column. Rabbit anti-
TET2 antibody was purchased from Proteintech Group (Chicago,
USA). All of these antibodies could speciﬁcally recognize the corre-
sponding proteins in immunoﬂuorescence and Western blotting (Zhao
et al., 2014; Mi et al., 2015; Fu et al., 2014). Rabbit anti-5hmC anti-
body (#39769) was purchased from Active Motif (Carlsbad, USA).
Quantitative RT-PCR
To obtain total RNA, Neuro2a cells were extracted using Trizol
Reagent (Invitrogen, Carlsbad USA). The RNA was subsequently
treated with RNase-free DNase I (Roche, Mannheim, Germany).
The isolated total RNA was reverse-transcribed for two-step quan-
titative RT-PCR (qRT-PCR) using the PrimeScript RT reagent kit
(TAKARA, Kyoto, Japan) according to the manufacturer’s instruc-
tions. Quantitative RT-PCR was carried out using a Peltier Thermal
Cycler (BioRad, Hercules, USA) plus Real time PCR Master Mix
(SYBR Green, Toyobo, Japan). Gene-speciﬁc primer pairs for PCR
are listed in Table S1. GAPDH was served as an internal control.
Plasmids
According to the target sequences of TET1, TET2, and TET3,
oligonucleotides encoding shRNA were designed, synthesized, and
inserted into pGPU6/GFP/Neo vector (Genepharma, Shanghai,
China) to generate recombinant plasmids expressing shRNAs
against TET1, TET2, and TET3, respectively. The target sequences
for shRNAs are listed in Table S2. The recombinant plasmids
expressing full-length TET1, inactive mutant of catalytic mutant (CD
mut), and CXXC-deleted mutant (dCXXC) of TET1 were kindly
provided by Dr. Li-Jung Juan (Hsu et al., 2012). The recombinant
plasmids expressing full-length TET2 and full-length TET3 were
obtained from Dr. Ross L. Levine (Abdel-Wahab et al., 2009) and Dr.
Toshinobu Nakamura (Nakamura et al., 2012).
Cell culture, transfection, and differentiation assay
Neuro2a cells were cultured in DMEM containing 10% fetal bovine
serum (FBS), 1% non-essential amino acid, and 1% penicillin and
streptomycin. Neuro2a cells were transfected using X-treme GENE
HP DNA Transfection Reagent (Roche, Mannheim, Germany)
according to the manufacturer’s instructions. To induce neuronal
differentiation, Neuro2a cells (about 20% conﬂuences) were trans-
ferred to serum-free opti-MEM (Gibco, Grand Island, New York,
USA) containing 1 mmol/L VPA for neurite extension.
Immunocytochemistry
Cells on Poly-L-Lysine-coated glass coverslips were ﬁxed with 4%
paraformaldehyde for 15 min at room temperature and then per-
meabilized by treatment with ice-cold methanol for 10 min. For
staining 5hmC, DNA was denatured with 2 mol/L HCl for 30 min, and
then neutralized with 0.1 mol/L Tris-HCl (pH 8.5) twice (10 min a
time). Subsequently, the cells were blocked by 15% normal donkey
serum for 30 min, and then were incubated at 4°C overnight with
primary antibody. The following antibodies dilutions were used: all
TETantibodies were used at 1:200, anti-5hmC (1:5000), anti-GAP43
(1:500), and anti-Flag (PTGlab; 1:200). Then, the cells were rinsed
and incubated for 2 h with ﬂuorescence-labeled secondary anti-
bodies. After washing, the coverslips were mounted with PBS con-
taining 50% glycerol and 5 μg/mL DAPI for nuclei staining.
Dot blotting
The genomic DNA of Neuro2a cells were isolated using the EZNA
Tissue DNA kit (OMEGA, Norcross, USA) and the DNA concentration
was measured by NanoDrop. Dot-blot assays have been described
previously (Ito et al., 2011). Brieﬂy, genomic DNA was spotted on
nylon membrane, and then baked at 80°C for 2 h. After blocked with
5% skimmed milk for 1 h, nylon membrane was incubated with the
anti-5hmC antibody (1:5000) overnight at 4°C, and then incubated
with POD-labeled secondary antibodies (1:12500; Roche, Mannheim,
Germany). The signals were detected by BM Chemiluminescence
Western Blotting kit (Roche, Mannheim, Germany). The densitometry
quantiﬁcation of dot-blot was analyzed by ImageProPlus 6.0.
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The procedure had been previously described (Chen et al., 2011). In
brief, the cells were lysed and the protein concentrations of the
lysates were determined. Then, the lysates were separated by 8%
SDS-PAGE and transferred to polyvinylidene ﬂuoride (PVDF)
membranes. The membranes were blocked, followed by incubation
with primary antibodies and then POD-labeled secondary antibodies
(1:12500; Roche, Mannheim, Germany). The primary antibodies
were used as follows: TuJ1 (1:1000), TET1 (1:500), srGAP3
(1:1000), and α-Tubulin (Santa Cruz; 1:5000). The signals were
detected by BM Chemiluminescence Western Blotting kit (Roche,
Mannheim, Germany).
Statistical analysis
For assessing differentiation, cells bearing neurite processes 1.5
times longer than cell bodies were considered to be differentiated.
Each group was analyzed by counting at least 300 cells. Assess-
ment of neurite outgrowth was evaluated by counting about 30 to 50
cells per condition. Neurite number and length were quantiﬁed using
Image Pro-Plus software. In each analysis, the data represent
mean ± SEM of at least three experiments. For comparison, statis-
tical signiﬁcance was tested by one-way ANOVA.
ACKNOWLEDGEMENTS
The authors thank Dr. Heinrich Leonhardt for generously providing
the GFP-tagged TET1-FL and TET1-ΔCXXC expression plasmids,
Dr. Ross Levine for Flag-TET2, Dr. Toshinobu Nakamura for Flag-
TET3, Dr. Li-Jung Juan for Flag-hTET1, Flag-hTET1-CD mut, and
Flag-hTET1-ΔCXXC plasmids. This work was supported by the
National Natural Science Foundation of China (Grant Nos.
31171033 and 81272801) and Shanghai Jiao Tong University Med-X
Fund (No.YG2014MS45).
ABBREVIATIONS
5caC, 5-carboxylcytosine; 5fC, 5-formylcytosine; 5hmC, 5-hydrox-
ymethylcytosine; 5mC, 5-methylcytosine; GAP43, growth associated
protein-43; Hdac, histone deacetylases; srGAP3, Slit-Robo Rho
GTPase-activating protein 3; TET proteins, ten-eleven translocation
proteins; TuJ1, class III β-Tubulin; VPA, valproic acid
COMPLIANCE WITH ETHICS GUIDELINES
Jie Gao, Yue Ma, Hua-Lin Fu, Qian Luo, Zhen Wang, Yu-Huan Xiao,
Hao Yang, Da-Xiang Cui, and Wei-Lin Jin declare that they have no
conﬂict of interest.
This article does not contain any studies with human or animal
subjects performed by the any of the authors.
OPEN ACCESS
This article is distributed under the terms of the Creative Commons
Attribution 4.0 International License (http://creativecommons.org/
licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to
the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made.
REFERENCES
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J,
Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R (2009)
Genetic characterization of TET1, TET2, and TET3 alterations in
myeloid malignancies. Blood 114(1):144–147
Brodeur GM, Bagatell R (2014) Mechanisms of neuroblastoma
regression. Nat Rev Clin Oncol 11(12):704–713
Chen K, Mi Y-J, Ma Y, Fu H-L, Jin W-L (2011) The mental retardation
associated protein, srGAP3 negatively regulates VPA-induced
neuronal differentiation of Neuro2A cells. Cell Mol Neurobiol 31
(5):675–686
Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu
Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C (2015)
TET1 is a tumor suppressor of hematopoietic malignancy. Nat
Immunol 16(6):653–662
Dawlaty MM, Breiling A, Le T, Raddatz G, Barrasa MI, Cheng AW,
Gao Q, Powell BE, Li Z, Xu M (2013) Combined deﬁciency of
Tet1 and Tet2 causes epigenetic abnormalities but is compatible
with postnatal development. Dev Cell 24(3):310–323
Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA,
Marques CJ, Andrews S, Reik W (2011) Dynamic regulation of
5-hydroxymethylcytosine in mouse ES cells and during differen-
tiation. Nature 473(7347):398–402
Fu H-L, Ma Y, Lu L-G, Hou P, Li B-J, Jin W-L, Cui D-X (2014) TET1
exerts its tumor suppressor function by interacting with p53-EZH2
pathway in gastric cancer. J Biomed Nanotechnol 10(7):1217–
1230
Göttlicher M, Minucci S, Zhu P, Krämer OH, Schimpf A, Giavara S,
Sleeman JP, Coco FL, Nervi C, Pelicci PG (2001) Valproic acid
deﬁnes a novel class of HDAC inhibitors inducing differentiation
of transformed cells. EMBO J 20(24):6969–6978
Hahn MA, Qiu R, Wu X, Li AX, Zhang H, Wang J, Jui J, Jin S-G,
Jiang Y, Pfeifer GP (2013) Dynamics of 5-hydroxymethylcytosine
and chromatin marks in Mammalian neurogenesis. Cell reports 3
(2):291–300
Hsu C-H, Peng K-L, Kang M-L, Chen Y-R, Yang Y-C, Tsai C-H, Chu
C-S, Jeng Y-M, Chen Y-T, Lin F-M (2012) TET1 suppresses
cancer invasion by activating the tissue inhibitors of metallopro-
teinases. Cell Rep 2(3):568–579
Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang
Y (2011) Tet proteins can convert 5-methylcytosine to 5-formyl-
cytosine and 5-carboxylcytosine. Science 333(6047):1300–1303
Jin C, Lu Y, Jelinek J, Liang S, Estecio MR, Barton MC, Issa J-PJ
(2014) TET1 is a maintenance DNA demethylase that prevents
methylation spreading in differentiated cells. Nucleic Acids Res
42(11):6956–6971
Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming G-L,
King JR, Song H, Sweatt JD (2013) TET1 controls CNS
5-methylcytosine hydroxylation, active DNA demethylation, gene
transcription, and memory formation. Neuron 79(6):1086–1093
Ko M, An J, Bandukwala HS, Chavez L, Äijö T, Pastor WA, Segal
MF, Li H, Koh KP, Lähdesmäki H (2013) Modulation of TET2
RESEARCH ARTICLE Jie Gao et al.









expression and 5-methylcytosine oxidation by the CXXC domain
protein IDAX. Nature 497(7447):122–126
Kriaucionis S, Heintz N (2009) The nuclear DNA base 5-hydrox-
ymethylcytosine is present in Purkinje neurons and the brain.
Science 324(5929):929–930
Li T, Yang D, Li J, Tang Y, Yang J, Le W (2015) Critical role of Tet3 in
neural progenitor cell maintenance and terminal differentiation.
Mol Neurobiol 51(1):142–154
Ma Y, Mi Y-J, Dai Y-K, Fu H-L, Cui D-X, Jin W-L (2013) The inverse
F-BAR domain protein srGAP2 acts through srGAP3 to modulate
neuronal differentiation and neurite outgrowth of mouse neurob-
lastoma cells. PLoS One 8(3):e57865
Mariani CJ, Vasanthakumar A, Madzo J, Yesilkanal A, Bhagat T, Yu
Y, Bhattacharyya S, Wenger RH, Cohn SL, Nanduri J (2014)
TET1-mediated hydroxymethylation facilitates hypoxic gene
induction in neuroblastoma. Cell Rep 7(5):1343–1352
Mi Y, Gao X, Dai J, Ma Y, Xu L, Jin W-L (2015) A Novel Function of
TET2 in CNS: Sustaining Neuronal Survival. Int J Mol Sci 16
(9):21846–21857
Nakamura T, Liu Y-J, Nakashima H, Umehara H, Inoue K, Matoba S,
Tachibana M, Ogura A, Shinkai Y, Nakano T (2012) PGC7 binds
histone H3K9me2 to protect against conversion of 5mC to 5hmC
in early embryos. Nature 486(7403):415–419
Neri F, Dettori D, Incarnato D, Krepelova A, Rapelli S, Maldotti M,
Parlato C, Paliogiannis P, Oliviero S (2015) TET1 is a tumour
suppressor that inhibits colon cancer growth by derepressing
inhibitors of the WNT pathway. Oncogene 34(32):4168–4176
Pastor WA, Aravind L, Rao A (2013) TETonic shift: biological roles of
TET proteins in DNA demethylation and transcription. Nat Rev
Mol Cell Biol 14(6):341–356
Perera A, Eisen D, Wagner M, Laube Silvia K, Künzel Andrea F,
Koch S, Steinbacher J, Schulze E, Splith V, Mittermeier N, Müller
M, Biel M, Carell T, Michalakis S (2015) TET3 is recruited by
REST for context-speciﬁc hydroxymethylation and induction of
gene expression. Cell Rep 11(2):283–294
Qiao Y, Wang X, Wang R, Li Y, Yu F, Yang X, Song L, Xu G, Chin YE,
Jing N (2015) AF9 promotes hESC neural differentiation through
recruiting TET2 to neurodevelopmental gene loci for methylcy-
tosine hydroxylation. Cell Discov 1:15017
Rudenko A, Dawlaty MM, Seo J, Cheng AW, Meng J, Le T, Faull KF,
Jaenisch R, Tsai L-H (2013) Tet1 is critical for neuronal activity-
regulated gene expression and memory extinction. Neuron 79
(6):1109–1122
Scourzic L, Mouly E, Bernard OA (2015) TET proteins and the
control of cytosine demethylation in cancer. Genome Med 7(1):9
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y,
Agarwal S, Iyer LM, Liu DR, Aravind L (2009) Conversion of
5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA
by MLL partner TET1. Science 324(5929):930–935
Tan L, Shi YG (2012) Tet family proteins and 5-hydroxymethylcy-
tosine in development and disease. Development 139(11):1895–
1902
Wang Y, Xiao M, Chen X, Chen L, Xu Y, Lv L, Wang P, Yang H, Ma S,
Lin H, Jiao B, Ren R, Ye D, Guan KL, Xiong Y (2015) WT1
recruits TET2 to regulate its target gene expression and suppress
leukemia cell proliferation. Mol Cell 57(4):662–673
Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PA,
Rappsilber J, Helin K (2011) TET1 and hydroxymethylcytosine in
transcription and DNA methylation ﬁdelity. Nature 473(7347):
343–348
Wu H, D’Alessio AC, Ito S, Xia K, Wang Z, Cui K, Zhao K, Sun YE,
Zhang Y (2011) Dual functions of Tet1 in transcriptional regulation
in mouse embryonic stem cells. Nature 473(7347):389–393
Xu Y, Xu C, Kato A, Tempel W, Abreu JG, Bian C, Hu Y, Hu D, Zhao
B, Cerovina T (2012) Tet3 CXXC domain and dioxygenase
activity cooperatively regulate key genes for Xenopus eye and
neural development. Cell 151(6):1200–1213
Yao B, Jin P (2014) Unlocking epigenetic codes in neurogenesis.
Genes Dev 28(12):1253–1271
Zhang R-R, Cui Q-Y, Murai K, Lim YC, Smith ZD, Jin S, Ye P, Rosa
L, Lee YK, Wu H-P (2013) Tet1 regulates adult hippocampal
neurogenesis and cognition. Cell Stem Cell 13(2):237–245
Zhang Q, Zhao K, Shen Q, Han Y, Gu Y, Li X, Zhao D, Liu Y, Wang
C, Zhang X (2015) Tet2 is required to resolve inﬂammation by
recruiting Hdac2 to speciﬁcally repress IL-6. Nature 525
(7569):389–393
Zhao X, Dai J, Ma Y, Mi Y, Cui D, Ju G, Macklin WB, Jin W-L (2014)
Dynamics of ten-eleven translocation hydroxylase family proteins
and 5-hydroxymethylcytosine in oligodendrocyte differentiation.
Glia 62(6):914–926
The non-catalytic activity of TET1 in neuronal differentiation RESEARCH ARTICLE
© The Author(s) 2016. This article is published with open access at Springerlink.com and journal.hep.com.cn 361
P
ro
te
in
&
C
e
ll
